 | • レポートコード：D0804-14406 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、αブロッカーの世界市場を広く調査・分析し、今後の市場展望をまとめております。αブロッカーの種類別市場規模（非選択的拮抗薬、選択的拮抗薬）、用途別市場規模（高血圧症、レイノー病、勃起不全）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Bristol-Myers Squibb、Astra Zeneca、Novartis、Sanofi、Merck、GSK、Eli Lilly、Jhonson and Johnson、Bayer、Teva Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・αブロッカーの北米市場（アメリカ、カナダ、メキシコ） ・αブロッカーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・αブロッカーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・αブロッカーの南米市場（ブラジル、アルゼンチン） ・αブロッカーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：非選択的拮抗薬、選択的拮抗薬 ・用途別分析：高血圧症、レイノー病、勃起不全 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global α-blocker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The α-blocker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
α-blocker market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, α-blocker market has been segmented into
Non-selective Antagonists
Selective Antagonists
By Application, α-blocker has been segmented into:
Hypertension
Raynaud’s Disease
Erectile Dysfunction
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global α-blocker market presented in the report. This section sheds light on the sales growth of different regional and country-level α-blocker markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global α-blocker market.
The report offers in-depth assessment of the growth and other aspects of the α-blocker market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and α-blocker Market Share Analysis
α-blocker competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, α-blocker sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the α-blocker sales, revenue and market share for each player covered in this report.
The major players covered in α-blocker are:
Pfizer
Bristol-Myers Squibb
Astra Zeneca
Novartis
Sanofi
Merck
GSK
Eli Lilly
Jhonson and Johnson
Bayer
Teva Pharmaceutical
Among other players domestic and global, α-blocker market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe α-blocker product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of α-blocker, with price, sales, revenue and global market share of α-blocker in 2018 and 2019.
Chapter 3, the α-blocker competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the α-blocker breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, α-blocker market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe α-blocker sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 α-blocker Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global α-blocker Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Non-selective Antagonists
1.2.3 Selective Antagonists
1.3 Market Analysis by Application
1.3.1 Overview: Global α-blocker Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hypertension
1.3.3 Raynaud’s Disease
1.3.4 Erectile Dysfunction
1.4 Overview of Global α-blocker Market
1.4.1 Global α-blocker Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol-Myers Squibb SWOT Analysis
2.2.4 Bristol-Myers Squibb Product and Services
2.2.5 Bristol-Myers Squibb α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astra Zeneca
2.3.1 Astra Zeneca Details
2.3.2 Astra Zeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astra Zeneca SWOT Analysis
2.3.4 Astra Zeneca Product and Services
2.3.5 Astra Zeneca α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GSK SWOT Analysis
2.7.4 GSK Product and Services
2.7.5 GSK α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly SWOT Analysis
2.8.4 Eli Lilly Product and Services
2.8.5 Eli Lilly α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Jhonson and Johnson
2.9.1 Jhonson and Johnson Details
2.9.2 Jhonson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Jhonson and Johnson SWOT Analysis
2.9.4 Jhonson and Johnson Product and Services
2.9.5 Jhonson and Johnson α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bayer SWOT Analysis
2.10.4 Bayer Product and Services
2.10.5 Bayer α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Teva Pharmaceutical
2.11.1 Teva Pharmaceutical Details
2.11.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Teva Pharmaceutical SWOT Analysis
2.11.4 Teva Pharmaceutical Product and Services
2.11.5 Teva Pharmaceutical α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global α-blocker Sales and Market Share by Manufacturer (2018-2019)
3.2 Global α-blocker Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 α-blocker Manufacturer Market Share in 2019
3.3.2 Top 6 α-blocker Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global α-blocker Sales, Revenue and Market Share by Regions
4.1.1 Global α-blocker Sales and Market Share by Regions (2015-2020)
4.1.2 Global α-blocker Revenue and Market Share by Regions (2015-2020)
4.2 North America α-blocker Sales and Growth Rate (2015-2020)
4.3 Europe α-blocker Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific α-blocker Sales and Growth Rate (2015-2020)
4.5 South America α-blocker Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa α-blocker Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America α-blocker Sales, Revenue and Market Share by Country
5.1.1 North America α-blocker Sales and Market Share by Country (2015-2020)
5.1.2 North America α-blocker Revenue and Market Share by Country (2015-2020)
5.2 United States α-blocker Sales and Growth Rate (2015-2020)
5.3 Canada α-blocker Sales and Growth Rate (2015-2020)
5.4 Mexico α-blocker Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe α-blocker Sales, Revenue and Market Share by Country
6.1.1 Europe α-blocker Sales and Market Share by Country (2015-2020)
6.1.2 Europe α-blocker Revenue and Market Share by Country (2015-2020)
6.2 Germany α-blocker Sales and Growth Rate (2015-2020)
6.3 UK α-blocker Sales and Growth Rate (2015-2020)
6.4 France α-blocker Sales and Growth Rate (2015-2020)
6.5 Russia α-blocker Sales and Growth Rate (2015-2020)
6.6 Italy α-blocker Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific α-blocker Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific α-blocker Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific α-blocker Revenue and Market Share by Regions (2015-2020)
7.2 China α-blocker Sales and Growth Rate (2015-2020)
7.3 Japan α-blocker Sales and Growth Rate (2015-2020)
7.4 Korea α-blocker Sales and Growth Rate (2015-2020)
7.5 India α-blocker Sales and Growth Rate (2015-2020)
7.6 Southeast Asia α-blocker Sales and Growth Rate (2015-2020)
7.7 Australia α-blocker Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America α-blocker Sales, Revenue and Market Share by Country
8.1.1 South America α-blocker Sales and Market Share by Country (2015-2020)
8.1.2 South America α-blocker Revenue and Market Share by Country (2015-2020)
8.2 Brazil α-blocker Sales and Growth Rate (2015-2020)
8.3 Argentina α-blocker Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa α-blocker Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa α-blocker Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa α-blocker Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia α-blocker Sales and Growth Rate (2015-2020)
9.3 Turkey α-blocker Sales and Growth Rate (2015-2020)
9.4 Egypt α-blocker Sales and Growth Rate (2015-2020)
9.5 South Africa α-blocker Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global α-blocker Sales and Market Share by Type (2015-2020)
10.2 Global α-blocker Revenue and Market Share by Type (2015-2020)
10.3 Global α-blocker Price by Type (2015-2020)
11 Global α-blocker Market Segment by Application
11.1 Global α-blocker Sales Market Share by Application (2015-2020)
11.2 Global α-blocker Revenue Market Share by Application (2015-2020)
11.3 Global α-blocker Price by Application (2015-2020)
12 Market Forecast
12.1 Global α-blocker Sales, Revenue and Growth Rate (2021-2025)
12.2 α-blocker Market Forecast by Regions (2021-2025)
12.2.1 North America α-blocker Market Forecast (2021-2025)
12.2.2 Europe α-blocker Market Forecast (2021-2025)
12.2.3 Asia-Pacific α-blocker Market Forecast (2021-2025)
12.2.4 South America α-blocker Market Forecast (2021-2025)
12.2.5 Middle East & Africa α-blocker Market Forecast (2021-2025)
12.3 α-blocker Market Forecast by Type (2021-2025)
12.3.1 Global α-blocker Sales Forecast by Type (2021-2025)
12.3.2 Global α-blocker Market Share Forecast by Type (2021-2025)
12.4 α-blocker Market Forecast by Application (2021-2025)
12.4.1 Global α-blocker Sales Forecast by Application (2021-2025)
12.4.2 Global α-blocker Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global α-blocker Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of α-blocker by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global α-blocker Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer α-blocker Major Business
Table 9. Pfizer α-blocker Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer α-blocker Product and Services
Table 12. Pfizer α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 14. Bristol-Myers Squibb α-blocker Major Business
Table 15. Bristol-Myers Squibb α-blocker Total Revenue (USD Million) (2017-2018)
Table 16. Bristol-Myers Squibb SWOT Analysis
Table 17. Bristol-Myers Squibb α-blocker Product and Services
Table 18. Bristol-Myers Squibb α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 20. Astra Zeneca α-blocker Major Business
Table 21. Astra Zeneca α-blocker Total Revenue (USD Million) (2017-2018)
Table 22. Astra Zeneca SWOT Analysis
Table 23. Astra Zeneca α-blocker Product and Services
Table 24. Astra Zeneca α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis Basic Information, Manufacturing Base and Competitors
Table 26. Novartis α-blocker Major Business
Table 27. Novartis α-blocker Total Revenue (USD Million) (2017-2018)
Table 28. Novartis SWOT Analysis
Table 29. Novartis α-blocker Product and Services
Table 30. Novartis α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi α-blocker Major Business
Table 33. Sanofi α-blocker Total Revenue (USD Million) (2017-2018)
Table 34. Sanofi SWOT Analysis
Table 35. Sanofi α-blocker Product and Services
Table 36. Sanofi α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck Basic Information, Manufacturing Base and Competitors
Table 38. Merck α-blocker Major Business
Table 39. Merck α-blocker Total Revenue (USD Million) (2017-2018)
Table 40. Merck SWOT Analysis
Table 41. Merck α-blocker Product and Services
Table 42. Merck α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. GSK Basic Information, Manufacturing Base and Competitors
Table 44. GSK α-blocker Major Business
Table 45. GSK α-blocker Total Revenue (USD Million) (2017-2018)
Table 46. GSK SWOT Analysis
Table 47. GSK α-blocker Product and Services
Table 48. GSK α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 50. Eli Lilly α-blocker Major Business
Table 51. Eli Lilly α-blocker Total Revenue (USD Million) (2017-2018)
Table 52. Eli Lilly SWOT Analysis
Table 53. Eli Lilly α-blocker Product and Services
Table 54. Eli Lilly α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Jhonson and Johnson Basic Information, Manufacturing Base and Competitors
Table 56. Jhonson and Johnson α-blocker Major Business
Table 57. Jhonson and Johnson α-blocker Total Revenue (USD Million) (2017-2018)
Table 58. Jhonson and Johnson SWOT Analysis
Table 59. Jhonson and Johnson α-blocker Product and Services
Table 60. Jhonson and Johnson α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Bayer Basic Information, Manufacturing Base and Competitors
Table 62. Bayer α-blocker Major Business
Table 63. Bayer α-blocker Total Revenue (USD Million) (2017-2018)
Table 64. Bayer SWOT Analysis
Table 65. Bayer α-blocker Product and Services
Table 66. Bayer α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceutical α-blocker Major Business
Table 69. Teva Pharmaceutical α-blocker Total Revenue (USD Million) (2017-2018)
Table 70. Teva Pharmaceutical SWOT Analysis
Table 71. Teva Pharmaceutical α-blocker Product and Services
Table 72. Teva Pharmaceutical α-blocker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global α-blocker Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global α-blocker Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global α-blocker Sales by Regions (2015-2020) (K Units)
Table 76. Global α-blocker Sales Market Share by Regions (2015-2020)
Table 77. Global α-blocker Revenue by Regions (2015-2020) (USD Million)
Table 78. North America α-blocker Sales by Countries (2015-2020) (K Units)
Table 79. North America α-blocker Sales Market Share by Countries (2015-2020)
Table 80. North America α-blocker Revenue by Countries (2015-2020) (USD Million)
Table 81. North America α-blocker Revenue Market Share by Countries (2015-2020)
Table 82. Europe α-blocker Sales by Countries (2015-2020) (K Units)
Table 83. Europe α-blocker Sales Market Share by Countries (2015-2020)
Table 84. Europe α-blocker Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific α-blocker Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific α-blocker Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific α-blocker Revenue by Regions (2015-2020) (USD Million)
Table 88. South America α-blocker Sales by Countries (2015-2020) (K Units)
Table 89. South America α-blocker Sales Market Share by Countries (2015-2020)
Table 90. South America α-blocker Revenue by Countries (2015-2020) (USD Million)
Table 91. South America α-blocker Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa α-blocker Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa α-blocker Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa α-blocker Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa α-blocker Revenue Market Share by Countries (2015-2020)
Table 96. Global α-blocker Sales by Type (2015-2020) (K Units)
Table 97. Global α-blocker Sales Share by Type (2015-2020)
Table 98. Global α-blocker Revenue by Type (2015-2020) (USD Million)
Table 99. Global α-blocker Revenue Share by Type (2015-2020)
Table 100. Global α-blocker Sales by Application (2015-2020) (K Units)
Table 101. Global α-blocker Sales Share by Application (2015-2020)
Table 102. Global α-blocker Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global α-blocker Market Share Forecast by Regions (2021-2025)
Table 104. Global α-blocker Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global α-blocker Market Share Forecast by Type (2021-2025)
Table 106. Global α-blocker Sales Forecast by Application (2021-2025)
Table 107. Global α-blocker Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. α-blocker Picture
Figure 2. Global Sales Market Share of α-blocker by Type in 2019
Figure 3. Non-selective Antagonists Picture
Figure 4. Selective Antagonists Picture
Figure 5. α-blocker Sales Market Share by Application in 2018
Figure 6. Hypertension Picture
Figure 7. Raynaud's Disease Picture
Figure 8. Erectile Dysfunction Picture
Figure 9. Global α-blocker Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia α-blocker Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey α-blocker Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global α-blocker Sales Market Share by Manufacturer in 2019
Figure 30. Global α-blocker Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 α-blocker Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 α-blocker Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global α-blocker Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global α-blocker Revenue Market Share by Regions (2015-2020)
Figure 37. Global α-blocker Revenue Market Share by Regions in 2018
Figure 38. North America α-blocker Sales and Growth Rate (2015-2020)
Figure 39. Europe α-blocker Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific α-blocker Sales and Growth Rate (2015-2020)
Figure 41. South America α-blocker Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa α-blocker Sales and Growth Rate (2015-2020)
Figure 43. North America α-blocker Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America α-blocker Sales Market Share by Countries (2015-2020)
Figure 45. North America α-blocker Sales Market Share by Countries in 2018
Figure 46. North America α-blocker Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America α-blocker Revenue Market Share by Countries in 2018
Figure 48. United States α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe α-blocker Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe α-blocker Revenue Market Share by Countries (2015-2020)
Figure 53. Europe α-blocker Revenue Market Share by Countries in 2019
Figure 54. Germany α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific α-blocker Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific α-blocker Sales Market Share by Regions 2019
Figure 61. Asia-Pacific α-blocker Revenue Market Share by Regions 2019
Figure 62. China α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America α-blocker Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America α-blocker Sales Market Share by Countries in 2019
Figure 69. South America α-blocker Revenue Market Share by Countries in 2019
Figure 70. Brazil α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa α-blocker Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa α-blocker Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa α-blocker Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa α-blocker Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa α-blocker Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global α-blocker Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global α-blocker Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales α-blocker Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales α-blocker Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales α-blocker Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales α-blocker Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales α-blocker Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
α-アドレナリン受容体拮抗薬の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global α-adrenoreceptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The α-adrenoreceptor…- 広告ブロッカーの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Advertisement Blockers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Advertisement Blockers…
- 勃起不全用ESWTユニットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Erectile Dysfunction ESWT Units market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Erectile Dysf…
- AT1受容体拮抗薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global AT1 Receptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The AT1 Receptor Antagon…
- AT1受容体拮抗薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global AT1 Receptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The AT1 Receptor Antagon…